Sunday 19 February 2017

Less than 2 weeks to Brazil (oh and that Yellow Fever thing).

Note: The FlyinOrange has moved to: flyinorange.blog

Mid January.

High off of the PB week in Valle over Christmas, my eyes start to look forward to early March and a 2nd tour with XC Brazil. The tour last year was met with one of the strongest El Nino events the region had ever seen that thought to bring with it a continuous onslaught of rain. The hope is that 2017 will prove drier (and far more flyable).

An email appears from the tour organizer, Steve Barton, suggesting that everyone arrange to get the Yellow Fever vaccine ASAP as a situation was starting to unfold within the state we would be flying (Minas Gerais - MG). For yours truly this presents a particular challenge. Being on a number of drugs that are contradictory to the vaccine means one of two things, get an exemption certificate for the vaccine or stop treatment. Fearing that the outbreak might not be brought under control in time by the authorities, I go with the latter.

Today.

Reading the latest news it looks as if this was the right call.

Tuesday is my date with the needle for YF. This turn of events has made for a window to get every other vaccine I might be missing out of the way (the drugs would have rendered them ineffective otherwise). Tetanus, typhoid, Hep A/B, cholera are all done with rabies (and a YF booster) likely after I get back. Future plans are for increasingly remote flying destinations so might as well get the shots done now.

The catch of course is with most of the treatment stopped, things are trending slowly for the worse. With joints now able to gauge the weather better than Enviro Canada, the kit for the trip is going to be trimmed to the bare minimum to reduce weight. On the plus side it will be a good test of the vol-biv load out I am contemplating taking to Nepal in 2018.

That said, it is all but a nuisance in light of the latest message from Steve today - daytime highs hitting 40C.

Less than 2 weeks and counting.

Bring it.

No comments:

Post a Comment